CERNER CORPORATION

(CERN)
Delayed Nasdaq  -  04:00 2022-06-07 pm EDT
94.92 USD   -0.05%
06/10CERNER CORPORATION(NASDAQGS : CERN) dropped from FTSE All-World Index
CI
06/08S&P Lowers Oracle Corp. Rating To 'BBB' On Cerner Acquisition; Rating Remains On CreditWatch Negative
MT
06/08Oracle Closes $28.3 Billion Acquisition of Cerner
MT
SummaryQuotesChartsNewsRatingsCompany 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Cerner Corporation, Elligo Health Research and Freenome Collaborate to Enable Clinical Trial Through the Learning Health Network to Help Advance Early Cancer Detection

05/18/2022 | 02:15pm EDT

Cerner Corporation, Elligo Health Research and Freenome are collaborating to enable a clinical trial through the Learning Health Network to help advance early cancer detection. Together they will be using the research-activated network of health systems, real-world data (RWD) and multiomics technology, developed by Freenome, with the goal to help accelerate early cancer detection. This will be one of the first cancer screening trials available to Cerner's rapidly growing Learning Health Network (LHN). Trial participation will help LHN members bring innovative cancer prevention testing to the communities they serve – no matter their size or where they are located. Freenome, Cerner and Elligo will team up to use RWD to drive the Sanderson Study, an upcoming clinical trial to detect multiple types of cancer which is IRB approved and uses new multiomics technology. Elligo Health Research will work with LHN members to accelerate site activation and enroll a large volume of diverse patients much faster than traditional recruitment models. Spanning the U.S., the collaboration will enable diverse patient participation, across a wide variety of demographics, socio-economic factors and all sizes of communities.


© S&P Capital IQ 2022
All news about CERNER CORPORATION
06/10CERNER CORPORATION(NASDAQGS : CERN) dropped from FTSE All-World Index
CI
06/08S&P Lowers Oracle Corp. Rating To 'BBB' On Cerner Acquisition; Rating Remains On Credit..
MT
06/08Oracle Closes $28.3 Billion Acquisition of Cerner
MT
06/08CERNER CORP : Completion of Acquisition or Disposition of Assets, Notice of Delisting or F..
AQ
06/08Oracle Completes Acquisition of Cerner
AQ
06/08Oracle Corporation completed the acquisition of Cerner Corporation.
CI
06/08CERNER CORPORATION(NASDAQGS : CERN) dropped from S&P Global 1200
CI
06/08CERNER CORPORATION(NASDAQGS : CERN) dropped from S&P 500 Health Care Equipment & Services ..
CI
06/08CERNER CORPORATION(NASDAQGS : CERN) dropped from S&P 500 Health Care
CI
06/08CERNER CORPORATION(NASDAQGS : CERN) dropped from S&P Composite 1500
CI
More news
Analyst Recommendations on CERNER CORPORATION
More recommendations
Chart CERNER CORPORATION
Duration : Period :
Cerner Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Managers and Directors
Dorian Estelle Daley President
Mark J. Erceg Chief Financial Officer & Executive Vice President
Jerome Labat Chief Technology Officer & Executive VP
Eva L. Karp Chief Clinical & Patient Safety Officer, Senior VP
Nasim Afsar Chief Health Officer
Sector and Competitors
1st jan.Capi. (M$)
CERNER CORPORATION2.21%27 916
THERMO FISHER SCIENTIFIC-11.54%228 785
DANAHER CORPORATION-12.77%208 770
INTUITIVE SURGICAL, INC.-33.45%85 396
EDWARDS LIFESCIENCES CORPORATION-18.09%65 379
SIEMENS HEALTHINEERS AG-21.45%59 158